These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8463182)

  • 1. Synergistic inhibition of human rhabdomyosarcoma cells by sodium phenylacetate and Tretinoin.
    Górski GK; McMorrow LE; Donaldson MH
    In Vitro Cell Dev Biol; 1993 Mar; 29A(3 Pt 1):189-91. PubMed ID: 8463182
    [No Abstract]   [Full Text] [Related]  

  • 2. Induction of myogenic differentiation in a human rhabdomyosarcoma cell line by phenylacetate.
    Cinatl J; Cinatl J; Herneiz P; Rabenau H; Hovak M; Benda R; Gümbel HO; Kornhuber B; Doerr HW
    Cancer Lett; 1994 Apr; 78(1-3):41-8. PubMed ID: 8180967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth inhibition of human melanoma tumor cells by the combination of sodium phenylacetate (NaPA) and substituted dextrans and one NaPA-dextran conjugate.
    Gervelas C; Avramoglou T; Crépin M; Jozefonvicz J
    Anticancer Drugs; 2002 Jan; 13(1):37-45. PubMed ID: 11914639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenylacetate synergizes with retinoic acid in inducing the differentiation of human neuroblastoma cells.
    Sidell N; Wada R; Han G; Chang B; Shack S; Moore T; Samid D
    Int J Cancer; 1995 Feb; 60(4):507-14. PubMed ID: 7829265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor growth inhibition, apoptosis, and Bcl-2 down-regulation of MCF-7ras tumors by sodium phenylacetate and tamoxifen combination.
    Adam L; Crépin M; Isräel L
    Cancer Res; 1997 Mar; 57(6):1023-9. PubMed ID: 9067263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenylacetate enhances the antiproliferative effect of retinoic acid in follicular thyroid cancer.
    Eigelberger MS; Wong MG; Duh QY; Clark OH
    Surgery; 2001 Dec; 130(6):931-5. PubMed ID: 11742319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid metabolism as a target for brain cancer therapy: synergistic activity of lovastatin and sodium phenylacetate against human glioma cells.
    Prasanna P; Thibault A; Liu L; Samid D
    J Neurochem; 1996 Feb; 66(2):710-6. PubMed ID: 8592143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro differentiation of human neuroblastoma cells induced by sodium phenylacetate.
    Cinatl J; Cinatl J; Mainke M; Weissflog A; Rabenau H; Kornhuber B; Doerr HW
    Cancer Lett; 1993 Jun; 70(1-2):15-24. PubMed ID: 8330296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic interactions between differentiation-inducing agents in inhibiting the proliferation of HL-60 human myeloid leukaemia cells in clonogenic micro assays.
    Hassan HT; Veit A; Maurer HR
    J Cancer Res Clin Oncol; 1991; 117(3):227-31. PubMed ID: 1709642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuronal cell differentiation of human neuroblastoma cells by inducing agents in combination.
    Rocchi P; Ferreri AM; Simone G; Bagnara GP; Paolucci G
    Anticancer Res; 1991; 11(5):1885-9. PubMed ID: 1768060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 13cis- and all-trans retinoic acid have antiproliferative effects on CML cells and render IFN alpha antiproliferative potency after combined treatment in vitro.
    Benthin M; Dallmann I; Atzpodien J
    Cancer Biother Radiopharm; 2001 Aug; 16(4):323-31. PubMed ID: 11603003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic growth inhibition of YM529 with biologic response modifiers (BRMs) in myeloma cells.
    Yata K; Otsuki T; Yamada O; Wada H; Yawata Y; Sugihara T
    Int J Hematol; 2002 Jun; 75(5):534-9. PubMed ID: 12095156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth inhibitory effects of aromatic fatty acids on ovarian tumor cell lines.
    Melichar B; Ferrandina G; Verschraegen CF; Loercher A; Abbruzzese JL; Freedman RS
    Clin Cancer Res; 1998 Dec; 4(12):3069-76. PubMed ID: 9865922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MGI 114: augmentation of antitumor activity when combined with topotecan.
    Weitman S; Barrera H; Moore R; Gonzalez C; Marty J; Hilsenbeck S; MacDonald JR; Waters SJ; Von Hoff D
    J Pediatr Hematol Oncol; 2000; 22(4):306-14. PubMed ID: 10959900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-clonogenic, in vitro assays for predicting sensitivity to cancer chemotherapy.
    Weisenthal LM; Su YZ; Duarte TE; Nagourney RA
    Prog Clin Biol Res; 1988; 276():75-92. PubMed ID: 3174684
    [No Abstract]   [Full Text] [Related]  

  • 16. Effective combination of ET-743 and doxorubicin in sarcoma: preclinical studies.
    Meco D; Colombo T; Ubezio P; Zucchetti M; Zaffaroni M; Riccardi A; Faircloth G; Jose J; D'Incalci M; Riccardi R
    Cancer Chemother Pharmacol; 2003 Aug; 52(2):131-8. PubMed ID: 12783202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiocytotoxic therapy in human non-small cell lung cancer cell lines--advantage of combined effects of TNP-470 and SN-38.
    Satoh H; Ishikawa H; Fujimoto M; Fujiwara M; Yamashita YT; Yazawa T; Ohtsuka M; Hasegawa S; Kamma H
    Acta Oncol; 1998; 37(1):85-90. PubMed ID: 9572659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined Antitumor Therapy with Metronomic Topotecan and Hypoxia-Activated Prodrug, Evofosfamide, in Neuroblastoma and Rhabdomyosarcoma Preclinical Models.
    Zhang L; Marrano P; Wu B; Kumar S; Thorner P; Baruchel S
    Clin Cancer Res; 2016 Jun; 22(11):2697-708. PubMed ID: 26719428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation of cultured human melanoma cells induced by the aromatic fatty acids phenylacetate and phenylbutyrate.
    Liu L; Shack S; Stetler-Stevenson WG; Hudgins WR; Samid D
    J Invest Dermatol; 1994 Sep; 103(3):335-40. PubMed ID: 8077698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of LNCaP proliferation and differentiation: actions and interactions of androgens, 1alpha,25-dihydroxycholecalciferol, all-trans retinoic acid, 9-cis retinoic acid, and phenylacetate.
    Esquenet M; Swinnen JV; Heyns W; Verhoeven G
    Prostate; 1996 Mar; 28(3):182-94. PubMed ID: 8628721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.